inactivation of angptl3 and cardiovascular disease
Published 7 years ago • 3.4K plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
2:26
genetic and pharmacological inactivation of angptl3 and cardiovascular disease
-
2:48
targeting ldl cholesterol with a small interfering rna
-
2:09
cardiovascular outcomes in patients with diabetes
-
1:57
treating vasodilatory shock
-
26:32
lipid management in 2019: from inclisaran to angptl3- evolution or revolution? - dr. robert rosenson
-
3:04
can lipoprotein(a) and calcium supplements cause aortic stenosis? (with dr. marc gillinov)
-
2:08
prevalence of rheumatic heart disease
-
1:41
pharmacotherapeutics of heart failure - abcd medication breakdown
-
2:20
genetic and pharmacological inactivation of angptl3 and cardiovascular disease by karen serrano
-
4:55
where does that ion go? a video of the cardiomyocyte action potential: part 2
-
7:01
hypercholesterolemia | how it works
-
2:09
effect of priming with anti-angiogenic therapy
-
2:15
lipoprotein(a) - familial hypercholesterolemia (fh) video series
-
2:03
high bmi and the global burden of disease
-
1:54
reducing the risk of preeclampsia in pregnant women | nejm
-
2:35
heart minute | to anticoagulate in af or not?
-
0:51
lipoprotein (a)
-
8:41
ehj today - decades of the renin angiontensin system
-
9:52
angiopoietin 2 levels are elevated in the 3rd trimester in the plasma of pre... (#5) – caroline dunk